Living with Psoriatic Arthritis is new a report conducted amongst 265 patients in France, Germany, Italy, Spain and UK. The report is based on the findings from 30-minute quantitative online and qualitative telephone interviews with patients. It will provide an update on the existing Living with PsA report published in 2016 and will be available to purchase in October 2019.
The report is intended to help pharmaceutical companies developing products in Psoriatic Arthritis to gain a deeper understanding of how patients come to be diagnosed with their disease and how their condition impacts their day-to-day lives physically, emotionally and socially. It also explores patient attitudes and perceptions towards treatment, the healthcare professionals managing their condition, as well as identifying the types of support and education patients need at key stages of their journey.
PsA is a chronic, inflammatory arthritis that can affect patients with psoriasis, with a prevalence ranging as wide as 6-40% among this group of patients. With no clear cause or cure, the negative impact of this condition on people’s lives can be immense.
Head of Living with, Mariel Metcalfe commented, “PsA places a heavy burden on patients physically and emotionally, and a significant amount of time may take place from the time a person experiences symptoms to getting a diagnosis and onto treatment. With the launch of new PsA treatments in recent years, it will be essential to capture the patient perspective not only about their condition, but also their experience with current treatments and further support they may require.”
To discover more, download our new interactive infographic to unlock key insights from various Living With reports to reveal patient behaviours, attitudes and unmet needs at different stages of their chronic disease journey. Download the infographic »
All the latest news from Research Partnership